IVD Data Integrity Concerns Are Increasingly 510(k)-Related
This article was originally published in The Gray Sheet
Executive Summary
In vitro diagnostic device 510(k) data will be getting a closer look from FDA, following a trend toward data integrity issues in premarket submissions
You may also be interested in...
Device Research Reg Compliance Trouble Spots Surveyed By BIMO Division
Cardiovascular, orthopedic and in vitro diagnostic device sectors in particular are encountering compliance difficulties, according to BIMO
Device Research Reg Compliance Trouble Spots Surveyed By BIMO Division
Cardiovascular, orthopedic and in vitro diagnostic device sectors in particular are encountering compliance difficulties, according to BIMO
Ventana Medical’s HPV Claims Probed By FDA In Vitro Diagnostic Office
Ventana Medical contends that its Inform HPV in-situ hybridization (ISH) probes qualify as analyte-specific reagents and do not require premarket notification, despite FDA's assertions to the contrary